Lisa Schots

Dose reduction of the new generation biologics (IL-17 and IL-23 inhibitors) in psoriasis: study protocol for an international, pragmatic, multicenter, randomized, controlled, non-inferiority study—the BeNeBio study

L. S. van der Schoot, J.M.P.A. van den Reek, Lynda Grine et al. · Trials · 2021 · 23 citations · Full text

Medicine, Dermatology, Pharmacology +15

Blocking interleukin‐17 in psoriasis: Real‐world experience from the <scp>PsoPlus</scp> cohort

Lisa Schots, Rani Soenen, Brigitte Blanquart et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 18 citations · Full text

Medicine, Dermatology, Immunology +16

Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis: results of a structured survey

Lisa Schots, Lynda Grine, Rani Soenen et al. · Journal of Dermatological Treatment · 2020 · 16 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis

Rani Soenen, Zhigang Wang, Lynda Grine et al. · Clinical and Experimental Dermatology · 2022 · 10 citations · Full text

Medicine, Dermatology, Pharmacology +14